Human umbilical tissue-derived cells (hUTC) represent an attractive cell source and a potential technology for neurorestoration and improvement of functional outcomes following stroke. Male Wistar rats were subjected to a transient middle cerebral artery occlusion (tMCAo) and were intravenously administered hUTC (N = 11) or vehicle (N = 10) 48 hrs after stroke. White matter and vascular reorganization was monitored over a 12-week period using MRI and histopathology. MRI results were correlated with neurological functional and histology outcomes to demonstrate that MRI can be a useful tool to measure structural recovery after stroke. MRI revealed a significant reduction in the ventricular volume expansion and improvement in cerebral blood fl...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceStroke, the leading cause of disability, lacks treatment beyond thrombolysis. ...
Stroke is a major cause of death and disability, with very limited treatment option. Cell-based ther...
Human umbilical tissue-derived cells (hUTC) represent an attractive cell source and a potential tech...
Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatme...
INTRODUCTION: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regene...
Ischemic stroke is a major cause of death and long-term disability in the Western society. It leaves...
After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite seve...
After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite seve...
Background. This study investigated behavioral recovery in rats following implanting increasing dose...
Systemic transplantation of mesenchymal stem cells (MSCs) is a promising approach for the treatment ...
Approximately 795,000 Americans experience a new or recurrent stroke each year (American Heart Assoc...
Stroke remains one of the most promising targets for cell therapy. Thorough preclinical efficacy tes...
BACKGROUND: Ischemic stroke is an acute brain insult that induces dramatic changes in the neurons. ...
Background.Human umbilical cordmultipotent mesenchymal stromal cells (UC-MSC) have recently been ide...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceStroke, the leading cause of disability, lacks treatment beyond thrombolysis. ...
Stroke is a major cause of death and disability, with very limited treatment option. Cell-based ther...
Human umbilical tissue-derived cells (hUTC) represent an attractive cell source and a potential tech...
Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatme...
INTRODUCTION: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regene...
Ischemic stroke is a major cause of death and long-term disability in the Western society. It leaves...
After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite seve...
After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite seve...
Background. This study investigated behavioral recovery in rats following implanting increasing dose...
Systemic transplantation of mesenchymal stem cells (MSCs) is a promising approach for the treatment ...
Approximately 795,000 Americans experience a new or recurrent stroke each year (American Heart Assoc...
Stroke remains one of the most promising targets for cell therapy. Thorough preclinical efficacy tes...
BACKGROUND: Ischemic stroke is an acute brain insult that induces dramatic changes in the neurons. ...
Background.Human umbilical cordmultipotent mesenchymal stromal cells (UC-MSC) have recently been ide...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceStroke, the leading cause of disability, lacks treatment beyond thrombolysis. ...
Stroke is a major cause of death and disability, with very limited treatment option. Cell-based ther...